Clinical trials
Phase 2 Myositis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 5 |
| Unknown status | 5 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University People's Hospital | 4 |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 3 |
| Novartis Pharmaceuticals | 3 |
| Kezar Life Sciences, Inc. | 2 |
| Amgen | 1 |
| Artiva Biotherapeutics, Inc. | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Cartesian Therapeutics | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Immunoforge Co. Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myositis | 27 |
| Dermatomyositis | 11 |
| Polymyositis | 9 |
| Myositis, Inclusion Body | 3 |
| Behcet Syndrome | 2 |
| Immunoglobulin G4-Related Disease | 2 |
| Lung Diseases, Interstitial | 2 |
| Muscular Diseases | 2 |
| Musculoskeletal Diseases | 2 |
| Scleroderma, Systemic | 2 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.